Episode Details

Back to Episodes

Alpha-lipoic acid: Oxidative stress, neuropathy, and glycemic control

Published 4 months ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/alpha-lipoic-acid-oxidative-stress-neuropathy-and-glycemic-control

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Introduction Alpha-lipoic acid (ALA) is a powerful antioxidant vitamin-like compound found naturally in foods like spinach and broccoli, and sold as a dietary supplement. It can neutralize damaging free radicals and help regenerate other antioxidants (like vitamins C and E), acting as a “cleanup crew” against oxidative stress () (). These properties have made ALA of great interest for protecting nerves in chronic diseases such as glaucoma and diabetes. Glaucoma involves slow loss of the optic nerve cells (retinal ganglion cells) often aided by oxidative damage, while diabetes causes high blood sugar and nerve damage. In this article we review the evidence on ALA’s effects in the eye and in blood sugar control, and discuss safety considerations. ALA for Glaucoma: Reducing Oxidative Stress and Protecting Nerves In glaucoma, damage to the optic nerve is linked not only to high eye pressure but also to reduced blood flow and oxidative stress in the retina. In fact, experts note “vascular factors may have important roles in the pathophysiology of glaucoma,” underlining the need to measure and improve ocular blood flow (). ALA, as an antioxidant, can help counter these processes. Laboratory studies show promising neuroprotective effects of ALA in glaucoma models. In one well-known study, mice prone to glaucoma were fed ALA in their diet. The treated mice showed higher expression of antioxidant genes and proteins in the retina, with lower levels of oxidative damage markers (damaged lipids, proteins, and DNA) compared to controls (). These mice also had better survival of retinal ganglion cells: after months of treatment the ALA-fed mice had healthier optic nerves and about 13% more optic nerve axons than untreated mice (). In other words, ALA slowed the loss of nerve fibers in glaucoma. The researchers concluded that ALA “reduces oxidative stress and improves RGC [retinal ganglion cell] survival in glaucoma” (). Clinical data in human glaucoma patients is still sparse, but some results are encouraging. For example, a small six-month study gave glaucoma patients a supplement containing R-alpha-lipoic acid (the active form of ALA) plus other antioxidants (vitamins C, E, lutein, omega-3, etc.). After 6 months the patients had significantly higher blood antioxidant capacity and much lower levels of malondialdehyde (a blood marker of oxidative damage) (). They also reported improved tear production (important for ocular surface health) and fewer dry-eye symptoms. Importantly, the supplement was well tolerated with no reported side effects or intolerances (). The authors noted that the antioxidant formula “counteracted oxidative stress […] and stabilized the functional parameters of the ocular surface and the glaucoma, without adverse effects” (). While this study included other nutrients beside ALA, it supports the idea that using ALA in a glaucoma-safe formula can boost antioxidant defenses in the eye. Animal and human studies together suggest ALA can help protect ocular nerves by reducing oxidative stress () (). Future clinical trials should look for objective eye measures of benefit. For example, optical coherence tomography (OCT) can measure the thickness of the retinal nerve fiber layer (RNFL) – a thinner RNFL indicates nerve loss in glaucoma. Inman et al. showed ALA helped preserve optic nerve fibers

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us